Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:51 AM UTC
| NCT Number | NCT01042379 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE2 |
| Target Enrollment | 5,000 participants |
| Active Locations | 42 sites in the US |
| Sponsor | QuantumLeap Healthcare Collaborative |
| Last Updated on CT.gov | May 6, 2026 (May 6, 2026) |
As of July 17, 2026: Clinical trial NCT01042379 is currently recruiting participants. This phase2 study for breast cancer is actively seeking new participants at 42 locations across the United States. The study is sponsored by QuantumLeap Healthcare Collaborative. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01042379 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 42 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01042379 was last updated May 6, 2026 (May 6, 2026). HelloStudys verifies this status automatically.